|
|
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure |
| 1R01AA029594-01A1 |
|
NIAAA |
2022 |
|
|
Cardiovascular disease in fetal alcohol spectrum disorder |
| 1U01AA030185-01 |
|
NIAAA |
2022 |
|
|
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) |
| 1U54AA030451-01 |
|
NIAAA |
2022 |
|
|
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder |
| 1U54AA030463-01 |
|
NIAAA |
2022 |
|
|
Prenatal Alcohol and Neuroimmunity |
| 5R01AA022460-08 |
|
NIAAA |
2022 |
|
|
Fetal alcohol exposure: effects on immunity of the premature newborn |
| 5R01AA027020-04 |
|
NIAAA |
2022 |
|
|
The placenta: a novel target of sex specific neurotoxicity by fire retardants |
| 5R01ES028110-05 |
|
NIEHS |
2022 |
|
|
Functional RNA Modifications, Micronutrient Exposure, Developmental Disabilities |
| 5R01ES031521-03 |
|
NIEHS |
2022 |
|
|
Mechanisms and indicators of inflammasome signaling in Parkinson’s disease |
| 5R01ES033462-02 |
|
NIEHS |
2022 |
|
|
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders |
| 5R35ES028366-04 |
|
NIEHS |
2022 |